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Introduction {#sec005}
============

Prostate cancer (PCa) involves a common male urinary system malignant tumour that has the highest incidence among European and American populations \[[@pone.0198055.ref001],[@pone.0198055.ref002]\]. This disease not only seriously affects the quality of life of patients but is also associated with financial burdens for society and the family \[[@pone.0198055.ref003],[@pone.0198055.ref004]\]. PCa is closely regulated by various cytokines, related genes and intercellular signalling networks in the course of its development. However, the specific molecular mechanisms remain unclear. Therefore, it is important to study the molecular mechanisms of prostate cancer and to prevent the disease and develop effective treatments.

miRNAs are a class of non-coding small RNAs that can be combined with the 3-\'UTR of target mRNA to regulate gene expression, which leads to abnormal expression of target genes. A large number of studies have reported abnormal expression of miRNAs in prostate cancer involving multiple miRNAs, such as miR-16, 221, 375, 1290 and 141 \[[@pone.0198055.ref005]--[@pone.0198055.ref007]\]. Abnormal miRNA expression has been confirmed to be closely related with long non-coding RNAs (lncRNAs) and transcription factors (TFs). lncRNAs regulate miRNA expression by binding and sequestering target miRNAs and participating in mRNA expression regulation \[[@pone.0198055.ref008],[@pone.0198055.ref009]\]. lncRNAs are emerging as novel diagnostic markers of PCa, and Chang et al. found that HOTAIR may participate in PCa progression\[[@pone.0198055.ref010]\]. Tian et al. revealed that RNCR3 functions as a tumour-promoting lncRNA in prostate cancer\[[@pone.0198055.ref011]\]. Li et al. found long noncoding RNA BDNF-AS is associated with clinical outcomes and plays a functional role in human prostate cancer\[[@pone.0198055.ref012]\]. As important factors in gene transcription and post-transcriptional regulation, TFs are also involved in controlling signaling pathways with miRNAs \[[@pone.0198055.ref013],[@pone.0198055.ref014]\]. A previous study found that CREB1 and FoxA1 associated with advanced prostate cancer, and CREB1/FoxA1 target gene panels can predict prostate cancer recurrence\[[@pone.0198055.ref015]\]. However, further research is needed to determine the regulatory mechanisms of miRNAs, lncRNAs, TFs and mRNAs in PCa.

Microarray analysis can quickly identify all genes that are expressed at the same time-point \[[@pone.0198055.ref016]\]. Future research could benefit from integration and analysis of these data \[[@pone.0198055.ref017]\]. In this work, we identified differentially expressed genes (DEGs) in prostate cancer from the GSE64318 \[[@pone.0198055.ref018]\] and GSE46602 \[[@pone.0198055.ref019]\] datasets. We performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis for significant DEGs. Furthermore, we analysed mRNA-miRNA-lncRNA and protein-protein interaction (PPI) networks to reveal interactions and identified some factors that may be associated with PCa regulatory mechanisms. Finally, we analysed hub genes based on the PPI network and TCGA datasets. This study will contribute to understanding the molecular mechanism of prostate cancer, providing valuable clues for further research.

Material and methods {#sec006}
====================

Raw data {#sec007}
--------

The datasets used in the present study were downloaded from the National Center of Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) (<https://www.ncbi.nlm.nih.gov/geo>/) \[[@pone.0198055.ref020]\]. The experimental articles that were used to compare the RNAs in prostate cancer tissue and noncancerous prostate tissue from patients were included. The original gene expression profiles were obtained from the GSE64318 \[[@pone.0198055.ref018]\] and GSE46602 datasets \[[@pone.0198055.ref019]\] ([S1](#pone.0198055.s001){ref-type="supplementary-material"} and [S2](#pone.0198055.s002){ref-type="supplementary-material"} Tables). The GSE64318 dataset includes microRNA expression profiles of prostate biopsy samples from 54 prostate biopsy specimens (27 tumours and 27 normal tissues). The platform used for these data is the GPL8227 Agilent-019118 Human miRNA Microarray 2.0 G4470B (miRNA ID version). The GSE46602 dataset includes genome expression profiling of tumour tissue specimens from 36 patients with prostate cancer and normal prostate biopsies from 14 patients. The platform used to analyse these data was the GPL570 Affymetrix Human Genome U133 Plus 2.0 Array.

Identification of differentially expressed genes {#sec008}
------------------------------------------------

GEO2R (<http://www.ncbi.nlm.nih.gov/geo/geo2r/>) is an interactive web tool based on the R language limma package \[[@pone.0198055.ref021]\] that can be used to compare two or more groups of samples to identify differential expression in a GEO series. In the present study, GEO2R was used to filter differentially expressed mRNAs and miRNAs between normal and tumour samples separately in each of the datasets. The false discovery rate (FDR) is a method of conceptualizing the rate of type I errors in null hypothesis testing when conducting multiple comparisons. GEO2R calculates the FDR automatically. The multiple t test was used to detect statistically significant genes at the same time with FDR correction. Fold change (FC) \>2 and P-value \<0.05 were set as the cut-off criteria. Probes without a corresponding gene symbol were then filtered.

Prediction of mRNA-miRNA-lncRNA interactions {#sec009}
--------------------------------------------

Interactions between differentially expressed miRNAs and differentially expressed mRNAs were predicted using miRWalk 3.0 (<http://mirwalk.umm.uni-heidelberg.de/>), which integrated the prediction results of both TargetScan \[[@pone.0198055.ref022]\] and miRDB \[[@pone.0198055.ref023]\], and a score ≥0.95 was considered as the cutoff criterion for the prediction analysis in miRWalk. Only the target mRNAs included in all of these databases were selected for the further analysis. The interaction between miRNA and lncRNA was predicted by using DIANA-LncBase v2.0 \[[@pone.0198055.ref024]\] and the score ≥0.4 was considered as cutoff criterion for the prediction analysis in the experimental module of LncBase. After the predicted targets were intersected with DEGs, miRNAs, lncRNAs and mRNAs were selected for further analysis. Cytoscape software (version 3.40) was used to visualize the regulatory network.

Gene function analysis {#sec010}
----------------------

The DAVID database (<http://david.abcc.ncifcrf.gov/>) was used to conduct gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis on significant DEGs and target genes of miRNAs with differential expression. The species was limited to Homo sapiens, and the "adjusted P-value (from the Benjamini--Hochberg method), 0.05" was considered statistically significant \[[@pone.0198055.ref025]\]. The GO terms included these three criteria: molecular function (MF), cellular component (CC), and biological process (BP).

Protein-protein interaction (PPI) network construction and analysis {#sec011}
-------------------------------------------------------------------

The protein-protein interaction network was constructed using the STRING online database. PPI pairs with a combined score ≥0.4 were used to construct the PPI network. Transcription factors were annotated using a TF checkpoint \[[@pone.0198055.ref026]\]. Then, the regulatory relationship between genes was visualized using Cytoscape software (version 3.4.0) and analysed through a topological property of the computing network including the degree distribution of the network using the CentiScaPe app \[[@pone.0198055.ref027]\]. Furthermore, the gene with a degree \>5 was defined as a hub gene in the regulatory network according to a previous study \[[@pone.0198055.ref028]\].

TCGA dataset analysis {#sec012}
---------------------

TCGA is a platform for researchers to download and assess free public datasets (<https://cancergenome.nih.gov/>) \[[@pone.0198055.ref029]\]. In the present study, we verified the expression of hub genes in TCGA datasets to improve the reliability of our analysis using an online tool, UALCAN (<http://ualcan.path.uab.edu/>) \[[@pone.0198055.ref030]\]. UALCAN used TCGA level 3 RNA-seq and clinical data from 31 cancer types. As described by Li and Dewey \[[@pone.0198055.ref031]\], the "scaled_estimate" was multiplied by 10^6^ to obtain transcripts per million (TPM) expression value using an in-house PERL (Practical Extraction and Report Language) program. As TPM has been suggested to be more comparable across samples than fragments per kilobase of transcript per million mapped reads (FPKM) and reads per kilobase of transcript per million mapped reads (RPKM) \[[@pone.0198055.ref032]\], TPM was used as the measure of expression here. Fifty-two normal samples and 497 primary tumour samples of prostate adenocarcinoma (PRAD) in TCGA datasets were included in the present study. Box and whisker plots were used to show hub gene expression levels between normal samples and primary tumour samples in PRAD.

Results {#sec013}
=======

Identification of differentially expressed mRNAs, miRNAs and lncRNAs {#sec014}
--------------------------------------------------------------------

The results show that 60 miRNAs, 1578 mRNAs and 128 lncRNAs were differentially expressed in prostate cancer ([S3](#pone.0198055.s003){ref-type="supplementary-material"}, [S4](#pone.0198055.s004){ref-type="supplementary-material"} and [S5](#pone.0198055.s005){ref-type="supplementary-material"} Tables). Analysis of the GSE64318 dataset led to the identification of 60 miRNAs in PCa tumour tissues compared with normal prostate tissues, including 35 up-regulated miRNAs and 25 down-regulated miRNAs. Analysis of the GSE46602 dataset led to the identification of 1578 mRNAs, including 583 up-regulated and 995 down-regulated mRNAs, and 128 lncRNAs, including 49 up-regulated and 79 down-regulated lncRNAs. We selected all significantly up-regulated and down-regulated mRNAs, miRNAs and lncRNAs to plot their expression on heat-maps and volcano plots ([Fig 1](#pone.0198055.g001){ref-type="fig"}). The top 10 significantly up-regulated and down-regulated miRNAs, mRNAs and lncRNAs are shown in Tables [1](#pone.0198055.t001){ref-type="table"}, [2](#pone.0198055.t002){ref-type="table"} and [3](#pone.0198055.t003){ref-type="table"}, respectively.

![Differentially expressed genes in prostate cancer (PCa) and normal prostate tissue.\
(A. Volcano plot of differentially expressed miRNAs. B. Heatmap of differentially expressed miRNAs. C. Volcano plot of differentially expressed mRNAs. D. Heatmap of differentially expressed mRNAs. E. Heatmap of differentially expressed lncRNAs).](pone.0198055.g001){#pone.0198055.g001}
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###### Top 10 significantly up-regulated and down-regulated miRNAs in the GSE64318 dataset.

![](pone.0198055.t001){#pone.0198055.t001g}

  miRNA_ID         Down/Up   logFC   adj.P.Val   P.Value
  ---------------- --------- ------- ----------- ----------
  hsa-miR-671-5p   Down      -1.58   0.003129    6.91E-05
  hsa-miR-923      Down      -1.5    0.01131     5.23E-04
  hsa-miR-483-5p   Down      -1.47   0.027441    2.04E-03
  hsa-miR-92b      Down      -1.42   0.004019    1.08E-04
  hsa-miR-150      Down      -1.35   0.002095    2.81E-05
  hsa-miR-498      Down      -1.31   0.007999    2.63E-04
  hsa-miR-933      Down      -1.3    0.000927    6.46E-06
  hsa-miR-765      Down      -1.3    0.001072    9.14E-06
  hsa-miR-563      Down      -1.24   0.006355    1.94E-04
  hsa-miR-665      Down      -1.21   0.003129    6.32E-05
  hsa-miR-221      Up        1.46    0.009099    3.21E-04
  hsa-miR-454      Up        1.46    0.029644    2.31E-03
  hsa-miR-26b      Up        1.47    0.034161    3.16E-03
  hsa-let-7a       Up        1.5     0.034161    3.02E-03
  hsa-miR-203      Up        1.51    0.003856    9.86E-05
  hsa-miR-148a     Up        1.62    0.004387    1.23E-04
  hsa-miR-183      Up        1.63    0.009145    3.34E-04
  hsa-miR-200a     Up        1.72    0.01323     7.09E-04
  hsa-miR-1        Up        1.92    0.034161    3.02E-03
  hsa-let-7f       Up        2.01    0.024917    1.79E-03

10.1371/journal.pone.0198055.t002

###### Top 10 significantly up-regulated and down-regulated mRNAs in the GSE46602 dataset.

![](pone.0198055.t002){#pone.0198055.t002g}

  Gene Symbol   Down/Up   logFC      adj.P.Val   P.Value
  ------------- --------- ---------- ----------- ----------
  CD177         Down      -6.06431   2.03E-09    1.89E-12
  NEFH          Down      -5.84333   3.13E-05    3.34E-07
  SLC14A1       Down      -5.45679   8.83E-10    7.15E-13
  KRT5          Down      -5.10424   2.09E-10    1.03E-13
  KRT15         Down      -4.99578   1.56E-10    7.00E-14
  TRIM29        Down      -4.96486   2.68E-11    7.36E-15
  TP63          Down      -4.90695   7.76E-11    2.98E-14
  JUP           Down      -4.73608   1.03E-09    9.03E-13
  NEFH          Down      -4.57684   5.07E-05    6.18E-07
  DST           Down      -4.55381   4.33E-08    7.60E-11
  CXCL14        Up        3.356898   2.96E-03    1.22E-04
  SIM2          Up        3.518509   2.60E-08    3.80E-11
  F5            Up        3.592734   1.63E-03    5.63E-05
  LUZP2         Up        3.789194   8.41E-05    1.21E-06
  PCA3          Up        3.822882   1.28E-04    2.08E-06
  AMACR         Up        3.830373   7.49E-07    2.88E-09
  GLYATL1       Up        3.928912   8.57E-07    3.45E-09
  AMACR         Up        4.307398   3.25E-07    1.02E-09
  DLX1          Up        4.410439   5.09E-06    3.35E-08
  PCA3          Up        4.558841   7.89E-06    5.87E-08

10.1371/journal.pone.0198055.t003

###### Top 10 significantly up-regulated and down-regulated lncRNAs in the GSE46602 dataset.

![](pone.0198055.t003){#pone.0198055.t003g}

  Gene Symbol      Location                    adj.P.Val   P.Value    logFC      Down/Up
  ---------------- --------------------------- ----------- ---------- ---------- ---------
  LINC00844        chr10:58999518--59001617    5.83E-09    6.18E-12   -4.45143   Down
  MIR205HG         chr1:209428820--209432552   4.37E-13    5.59E-17   -3.34821   Down
  RP11-44F21.5     chr4:75081702--75084717     2.14E-07    6.06E-10   -3.01543   Down
  RP11-680G24.5    chr16:15018106--15020488    1.49E-05    1.28E-07   -2.57293   Down
  RP11-203B7.2     chr4:146052604--146056762   2.96E-07    9.10E-10   -2.25844   Down
  MAGI2-AS3        chr7:79452957--79471208     1.29E-07    3.08E-10   -1.94617   Down
  LSAMP-AS1        chr3:116360024--116370085   4.05E-06    2.48E-08   -1.94409   Down
  LINC00937        chr12:8356963--8390752      1.63E-04    2.83E-06   -1.93046   Down
  LINC00883        chr3:107240692--107326964   3.22E-04    6.79E-06   -1.86947   Down
  PGM5-AS1         chr9:68355164--68357866     4.00E-02    4.20E-03   -1.86179   Down
  RP5-1092A3.4     chr1:28239509--28241453     1.16E-01    2.21E-02   1.132616   Up
  LINC01023        chr5:108727825--108728261   9.06E-04    2.61E-05   1.13526    Up
  LINC01128        chr1:827591--859446         4.49E-02    5.00E-03   1.199525   Up
  BAIAP2-AS1       chr17:81029133--81034719    1.48E-03    4.96E-05   1.201015   Up
  RP11-48B3.4      chr8:80541300--80543104     1.15E-02    7.49E-04   1.284279   Up
  RP11-339B21.15   chr9:128305161--128305515   6.32E-05    8.40E-07   1.310892   Up
  GABPB1-AS1       chr15:50354174--50358312    8.11E-04    2.26E-05   1.367447   Up
  RP11-391M1.4     chr3:40466466--40468587     7.89E-06    5.87E-08   1.489649   Up
  RP11-295G20.2    chr1:231522517--231528556   7.32E-04    1.96E-05   1.673082   Up
  LINC00992        chr5:117415512--117579744   1.90E-04    3.44E-06   2.288701   Up

mRNA-miRNA-lncRNA network analysis {#sec015}
----------------------------------

The miRNA--mRNA regulatory network was constructed. Interaction analysis shows that 33 differentially expressed miRNAs targeted 143 mRNAs, up-regulating or down-regulating them ([Fig 2](#pone.0198055.g002){ref-type="fig"}). In detail, 25 over-expressed miRNAs down-regulate 104 mRNAs, while 8 under-expressed miRNAs up-regulate 15 mRNAs. Subsequently, we reconstructed the lncRNA--miRNA--mRNA network after selecting the pre-treated data with P-values \<0.05 and fold change \>2 ([Fig 3](#pone.0198055.g003){ref-type="fig"}). In the network, there are 5 miRNA nodes, 13 lncRNA nodes, and 45 mRNA nodes. In detail, 9 under-expressed lncRNAs up-regulate 19 miRNAs, while 5 over-expressed miRNAs down-regulate 44 mRNAs.

![miRNA--mRNA regulatory network.\
Every node represents one gene, and each edge represents the interaction between genes. miRNAs are indicated with a V-shape, and mRNAs are indicated with circles. The colour red represents high expression, and blue represents low expression. There were 33 miRNAs, 143 mRNAs and 179 edges in the network.](pone.0198055.g002){#pone.0198055.g002}

![mRNA-miRNA-lncRNA regulatory network.\
Every node represents one gene, and each edge represents the interaction between genes. mRNAs, miRNAs and lncRNAs are indicated with circles, V-shapes and diamond shapes, respectively. The colour red represents high expression, and blue represents low expression. There were 13 lncRNAs, 5 miRNAs, 45 mRNAs and 81 edges in the network.](pone.0198055.g003){#pone.0198055.g003}

Function enrichment analysis of DEGs {#sec016}
------------------------------------

GO enrichment analyses for DEGs based on the mRNA-miRNA-lncRNA network were performed. The top 10 most significant GO terms of each group were shown. On the MF level, the DEGs were mainly enriched in sequence-specific DNA binding. On the CC level, the DEGs were mainly enriched in the nucleus, cytoplasm and plasma membrane. On the BP level, the DEGs were mainly enriched in positive regulation of transcription from the RNA polymerase II promoter, cell proliferation and cell migration. The top 20 most significant KEGG pathway terms are shown. The genes were mainly enriched in the PI3K-Akt signalling pathway, pathways in cancer and the focal adhesion signalling pathway ([Fig 4](#pone.0198055.g004){ref-type="fig"}, [S1 File](#pone.0198055.s006){ref-type="supplementary-material"}).

![Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) enrichment analysis.\
(A. The top 20 most significant KEGG pathway terms. B. The top 10 most significant changes in the GO biological process. C. The top 10 most significant changes in the GO cellular component. D. The top 10 most significant changes in the GO molecular function.).](pone.0198055.g004){#pone.0198055.g004}

Protein-protein interaction network (PPI) analysis {#sec017}
--------------------------------------------------

Using the STRING online database and Cytoscape software, a total of 128 of the 1578 DEGs were mapped into the PPI network complex. In this network, with a degree \>5, 32 nodes were chosen as hub nodes, including 2 TFs, 14 miRNAs, and 16 mRNAs; the results are presented in [Table 4](#pone.0198055.t004){ref-type="table"}, [Fig 5](#pone.0198055.g005){ref-type="fig"} and [S2 File](#pone.0198055.s007){ref-type="supplementary-material"}. Moreover, we found that 6 mRNAs (i.e., EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT) exhibited higher degrees (\>10) and miRNA-mRNA pairs. These findings suggest that these nodes may play important roles in the development of PCa.

![Protein-protein interaction (PPI) network.\
mRNAs and miRNAs are indicated with circles sand arrows, respectively. TFs are indicated with black-traced circles. The green dotted line indicates the interaction of the miRNAs-mRNAs. The orange line indicates the relationship of the interaction of the proteins. The colour red represents high expression, and green represents low expression.](pone.0198055.g005){#pone.0198055.g005}

10.1371/journal.pone.0198055.t004

###### Topology parameters of hub genes (degree \>5) in the miRNA-mRNA-TF regulatory network.

![](pone.0198055.t004){#pone.0198055.t004g}

  Gene           Closeness     Betweenness   Degree
  -------------- ------------- ------------- --------
  EGFR           0.00212766    4046.701286   22
  VEGFA          0.002159827   4331.82023    20
  hsa-miR-20b    0.001855288   2752.2272     16
  hsa-miR-20a    0.001821494   2973.867274   16
  hsa-let-7b     0.001481481   2436.558748   16
  hsa-let-7a     0.001582278   1383.644882   14
  hsa-let-7d     0.00174216    2553.049636   13
  PIK3R1         0.002057613   2045.442867   12
  DLG4           0.001869159   3167.065846   12
  TGFBR1         0.001976285   3691.770395   11
  KIT            0.001904762   1517.550434   11
  hsa-miR-23b    0.001587302   1375.820161   10
  PTEN           0.001923077   1345.754047   10
  hsa-miR-301a   0.001610306   1995.023424   9
  LDLR           0.001960784   1888.001784   9
  FLT1           0.001930502   1179.255452   9
  hsa-miR-200b   0.001445087   1353.57487    8
  hsa-miR-148a   0.00140647    1235.527073   8
  PPARGC1A       0.001801802   1571.190602   8
  BCL2L11        0.001834862   1606.829419   8
  NR3C1\*        0.00177305    733.3472529   7
  NRG1\*         0.001872659   1359.250724   7
  hsa-miR-98     0.001618123   802.5761652   7
  hsa-miR-92b    0.001506024   1655.33632    7
  GJA1           0.001745201   1149.048086   7
  hsa-miR-96     0.001335113   1416.966025   6
  hsa-miR-454    0.001420455   1854.243032   6
  hsa-miR-145    0.001461988   1257.608267   6
  TFRC           0.001821494   445.8511305   6
  ITGB8          0.001808318   2026.300029   6
  EPHA5          0.001689189   845.4402231   6
  CAMK2D         0.001620746   1045.62274    6

\* transcription factors (TFs).

TCGA dataset analysis {#sec018}
---------------------

TCGA dataset analyses were performed to demonstrate that aberrant expression of the hub genes, including EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT, were significantly different between PCa and normal prostate tissues ([Fig 6](#pone.0198055.g006){ref-type="fig"}).

![TCGA dataset analysis.\
(A. DLG4 expression in PCa. B. EGFR expression in PCa. C. KIT expression in PCa. D. PIK3R1 expression in PCa. E. VEGFA expression in PCa. F. TGFBR1 expression in PCa).](pone.0198055.g006){#pone.0198055.g006}

Discussion {#sec019}
==========

Prostate cancer (PCa) has become a public health issue of great concern worldwide \[[@pone.0198055.ref033]\]. However, the molecular mechanisms involved in PCa progression are still unclear. Therefore, it is crucial to study the mechanism and identify molecular targets for diagnosis and treatment. A number of studies have found that the development of PCa is related to a variety of signalling pathways, and mRNAs, miRNAs, lncRNAs and TFs play important regulatory roles. In this study, we performed a comprehensive bioinformatics analysis and retrieved mRNAs, miRNAs, lncRNAs and TFs in the interaction network, revealing key genes associated with prostate cancer.

miRNA expression in tumour tissues often differs from that of normal tissue, and this differential expression affects the occurrence, development and prognosis of tumours \[[@pone.0198055.ref034],[@pone.0198055.ref035]\]. Studies have confirmed that miRNA expression profiles can be used as biomarkers for the early detection, classification and prognosis of tumours \[[@pone.0198055.ref036],[@pone.0198055.ref037]\]. lncRNAs act as miRNA sponges and can regulate miRNA abundance and compete with mRNA for miRNA binding \[[@pone.0198055.ref038]\]. By constructing an mRNA-miRNA-lncRNA network, we found that the aberrant expression of lncRNAs led to abnormal expression of 5 miRNAs (i.e., has-miR-20a, has-miR-20b, has-miR-23b, has-let-7a and has-let-7d) in PCa and thus regulated the expression of target mRNAs. A previous study demonstrated that 5 miRNAs regulate the development of prostate cancer by targeting specific mRNAs and play an important role in the regulation of prostate cancer \[[@pone.0198055.ref039]--[@pone.0198055.ref041]\]. The involvement of key lncRNAs including HYMAI, MEG3, IPO5P1, MAG12-AS3, RMST and TRG-AS1 are important. Among them, MEG3 is an important tumour suppressor gene that inhibits cell proliferation and induces apoptosis in PCa \[[@pone.0198055.ref042]\]. The discovery of these lncRNAs suggests potential diagnostic and therapeutic targets for PCa.

Next, we conducted a functional enrichment analysis of the DEGs based on the mRNA-miRNA-lncRNA network. We found that the DEGs were mainly enriched in the nucleus and cytoplasm, were involved in transcriptional regulation, were related to sequence-specific DNA binding and participated in regulation of the PI3K-Akt signalling pathway, which is related to cancer, and the focal adhesion signalling pathway. To further analyse the key genes related to PCa, we constructed a PPI network. More significantly, we found that the transcription factor NR3C1 was a hub gene that participates in regulation of the expression of multiple miRNAs (has-miR-20a, has-miR-20b, has-miR-23b). Puhr M et al. assessed NR3C1 expression and the functional significance in tissues from PCa and found that it is a key factor for the development of PCa \[[@pone.0198055.ref043]\]. Moreover, we found that its regulatory function is similar to MEG3 and its down-regulation leads to increased expression of miRNAs (has-miR-20a, has-miR-20b, and has-miR-23b). Based on these results, we speculate that some regulatory relationship may exist between NR3C1 and MEG3.

Finally, through PPI and TCGA dataset analyses, we found that 6 mRNAs (i.e., EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT) had higher degrees and miRNA-mRNA pairs. This expression was lower and significantly different between PCa and normal prostate tissues. EGFR belongs to a family of cell membrane receptor tyrosine kinases and is a key factor in tumour cell growth and invasion \[[@pone.0198055.ref044],[@pone.0198055.ref045]\]. Previous studies have demonstrated that abnormal expression of EGFR and its downstream signalling contributes to disease progression in PCa \[[@pone.0198055.ref046]\]. EGFR downregulation is associated with enhanced signalling \[[@pone.0198055.ref047]\], which can lead to the development of cancer \[[@pone.0198055.ref048]\]. VEGFA is a mitogen with high endothelial cell specificity that plays a major regulatory role in the development of PCa \[[@pone.0198055.ref049]\]. A previous study found that PIK3R1, TGFBR1 and KIT might have clinical utility in distinguishing PCa \[[@pone.0198055.ref050]--[@pone.0198055.ref052]\]. EGFR can regulate VEGF expression by influencing MAPK and PI3K signalling pathways\[[@pone.0198055.ref053]\]. TGFBR1, DLG4 and KIT are also related to the regulation of MAPK and PI3K signalling pathways\[[@pone.0198055.ref054]\]. Our results further confirmed the potential biological relevance of 6 mRNAs in PCa. We also found that 6 mRNAs (EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT) were associated with abnormal expression of 5 miRNAs (has-miR-20a, has-miR-20b, has-miR-23b, has-let-7a and has-let-7d) in PCa. In conclusion, the hub genes that we identified may play crucial roles in PCa.

Conclusion {#sec020}
==========

We constructed and analysed mRNAs, miRNAs, lncRNAs, and TF interaction networks to reveal the key genes associated with prostate cancer. We found that 5 miRNAs (has-miR-20a, has-miR-20b, has-miR-23b, has-let-7a and has-let-7d), 6 lncRNAs (HYMAI, MEG3, IPO5P1, MAG12-AS3, RMST and TRG-AS1), 6 mRNAs (EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT) and 2 TFs (NR3C1, NRG1) play important regulatory roles in the interaction network. The expression levels of EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT were significantly different between PCa and normal tissues. Further research is needed to specify the molecular mechanism of these hub genes in PCa.
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